NCT07895433

Rifaximin for Prevention of Recurrent Mild-to-moderate Ascending Cholangitis After Biliary-enteric Anastomosis

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2026-10Est. Completion: 2027-10

Enrollment target: 60 participants

Contact

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.